Journal of Organic Chemistry 2010-02-05

Predominant (S)-enantioselective inclusion of aryl methyl sulfoxides by (S)-isoleucyl-(S)-phenylglycines.

Motohiro Akazome, Ai Doba, Shoji Matsumoto, Katsuyuki Ogura

Index: J. Org. Chem. 75(3) , 660-5, (2010)

Full Text: HTML

Abstract

In terms of chiral recognition for racemic aryl methyl sulfoxides in the solid state, three kinds of crystalline (S)-alkylglycyl-(S)-phenylglycines were examined as potential dipeptides host molecules. When (S)-alanyl-(S)-phenylglycines [(S,S)-Ala-Phg] crystallized with aryl methyl sulfoxides, the stereochemistry of preferentially included sulfoxides depended on the individual shapes of the sulfoxides and the enantiomeric excess was relatively low. Although (S)-leucyl-(S)-phenylglycines [(S,S)-Leu-Phg] and (S)-isoleucyl-(S)-phenylglycines [(S,S)-Ile-Phg] mainly included the S-form of aryl methyl sulfoxides, the enantiomeric recognition of (S,S)-Ile-Phg was superior to that of (S,S)-Leu-Phg. Single-crystal X-ray analysis of these inclusion compounds revealed that the dipeptide molecules self-assembled to form layer structures and included sulfoxides between these layers through hydrogen bonding between the proton of (+)NH(3) and the oxygen of the sulfoxide. Besides these host-guest interactions, the phenyl groups of the sulfoxides interacted with each other through the phenyl-phenyl interaction. Two adjacent homochiral sulfoxides make a pair having a 2-fold screw axis along the channel cavity. Thus, the self-recognition of sulfoxides made 2(1) helical column structures and had high enantioselectivity.


Related Compounds

  • H-Phg-OH
  • D-2-Phenylglycine
  • 2-Phenylglycine

Related Articles:

Glyphosate suppresses the antagonistic effect of Enterococcus spp. on Clostridium botulinum.

2013-04-01

[Bioorg. Med. Chem. Lett. 16 , 1138-41, (2006)]

Two plate-based colorimetric assays for screening α-amino acid ester hydrolase with high synthesis/hydrolysis ratio.

2012-07-15

[Enzyme Microb. Technol. 51(2) , 107-12, (2012)]

Mutation-specific potency and efficacy of cystic fibrosis transmembrane conductance regulator chloride channel potentiators.

2009-09-01

[J. Pharmacol. Exp. Ther. 330(3) , 783-91, (2009)]

Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein DeltaF508-CFTR.

2010-01-01

[Bioorg. Med. Chem. Lett. 20(1) , 87-91, (2010)]

Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.

2005-12-01

[Bioorg. Med. Chem. Lett. 15(23) , 5344-52, (2005)]

More Articles...